Merit Medical Systems, Inc.

NasdaqGS MMSI

Merit Medical Systems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 45.67%

Merit Medical Systems, Inc. Gross Profit Margin is 45.67% for the Trailing 12 Months (TTM) ending September 30, 2024, a -1.39% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Merit Medical Systems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 46.31%, a 2.49% change year over year.
  • Merit Medical Systems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 45.19%, a 1.86% change year over year.
  • Merit Medical Systems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 44.36%, a 6.45% change year over year.
  • Merit Medical Systems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 41.67%, a -4.96% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
NasdaqGS: MMSI

Merit Medical Systems, Inc.

CEO Mr. Fred P. Lampropoulos
IPO Date May 14, 1990
Location United States
Headquarters 1600 West Merit Parkway
Employees 6,950
Sector Health Care
Industries
Description

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Similar companies

HAE

Haemonetics Corporation

USD 79.96

0.69%

NVST

Envista Holdings Corp

USD 18.85

-0.74%

ATR

AptarGroup, Inc.

USD 154.61

0.47%

COO

The Cooper Companies, Inc.

USD 89.11

-2.38%

TFX

Teleflex Incorporated

USD 179.17

0.35%

WST

West Pharmaceutical Services, Inc.

USD 328.96

-3.13%

RMD

ResMed Inc.

USD 228.83

-0.62%

XRAY

DENTSPLY SIRONA Inc.

USD 18.06

-3.21%

ICUI

ICU Medical, Inc.

USD 161.08

1.85%

ANGO

AngioDynamics, Inc.

USD 11.80

-5.30%

StockViz Staff

January 15, 2025

Any question? Send us an email